CalciMedica, Inc. rose 11.4% on Monday, November 9, 2026, on 89,500 shares. No headline about CALC came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
CalciMedica, Inc. (CALC:NASDAQ) closed at $1.21 on November 13, 2026, down 0.82% on the day. The stock trades 96.6% below its 52-week high of $36.00 and 21.0% above its 52-week low of $1.00. Over the past year, it lost 92.3%. CalciMedica, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, CALC closed higher on 110 days (44%). Its best day was June 26, 2026 (+30.35%) and its worst was January 28, 2026 (-75.59%). The stock moved 10% or more in a single session 34 times. It opened at least 5% above the previous day's high 3 times.
Graybug Vision Inc is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. The company products under pipeline are; GB-501, a gene therapy delivered via a recombinant adeno-associated virus (AAV) vector to treat corneal clouding caused by mucopolysaccharidosis type 1 (MPS1), and GB-701, a novel and potent small-molecule complement factor B inhibitor being developed to target the complement pathway as a potential treatment for geographic atrophy (GA).
Find more stocks like CALC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.